208 related articles for article (PubMed ID: 17551365)
21. HLA-B27 misfolding and spondyloarthropathies.
Colbert RA; DeLay ML; Layh-Schmitt G; Sowders DP
Prion; 2009; 3(1):15-26. PubMed ID: 19363299
[TBL] [Abstract][Full Text] [Related]
22. Animal models of HLA-B27-associated diseases: new outcomes.
Hacquard-Bouder C; Ittah M; Breban M
Joint Bone Spine; 2006 Mar; 73(2):132-8. PubMed ID: 16377230
[TBL] [Abstract][Full Text] [Related]
23. The V249I polymorphism of the CX3CR1 gene is associated with fibrostenotic disease behavior in patients with Crohn's disease.
Sabate JM; Ameziane N; Lamoril J; Jouet P; Farmachidi JP; Soulé JC; Harnois F; Sobhani I; Jian R; Deybach JC; de Prost D; Coffin B
Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):748-55. PubMed ID: 18617779
[TBL] [Abstract][Full Text] [Related]
24. Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population.
Ernst A; Jacobsen B; Østergaard M; Okkels H; Andersen V; Dagiliene E; Pedersen IS; Thorsgaard N; Drewes AM; Krarup HB
Scand J Gastroenterol; 2007 Dec; 42(12):1445-51. PubMed ID: 17852840
[TBL] [Abstract][Full Text] [Related]
25. Intestinal permeability in families with Crohn's disease.
J Med Genet; 2006 Dec; 43(12):923. PubMed ID: 17142621
[No Abstract] [Full Text] [Related]
26. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease.
Peyrin-Biroulet L; Chamaillard M
J Endotoxin Res; 2007; 13(3):135-9. PubMed ID: 17621555
[TBL] [Abstract][Full Text] [Related]
27. Correlation between dendritic cell functional defect and spondylarthritis phenotypes in HLA-B27/HUMAN beta2-microglobulin-transgenic rat lines.
Fert I; Glatigny S; Poulain C; Satumtira N; Dorris ML; Taurog JD; Breban M
Arthritis Rheum; 2008 Nov; 58(11):3425-9. PubMed ID: 18975325
[TBL] [Abstract][Full Text] [Related]
28. HLA-B*2709 and spondylarthropathies: comment on the concise communication by Olivieri et al.
Mathieu A; Sorrentino R
Arthritis Rheum; 2003 Mar; 48(3):866-7; author reply 867-8. PubMed ID: 12632458
[No Abstract] [Full Text] [Related]
29. Therapy insight: how the gut talks to the joints--inflammatory bowel disease and the spondyloarthropathies.
Meier C; Plevy S
Nat Clin Pract Rheumatol; 2007 Nov; 3(11):667-74. PubMed ID: 17968338
[TBL] [Abstract][Full Text] [Related]
30. The clinical experience of antisense therapy to ICAM-1 in Crohn's disease.
Yacyshyn B; Bowen-Yacyshyn MB; Shanahan W
Curr Opin Mol Ther; 1999 Jun; 1(3):332-5. PubMed ID: 11713798
[TBL] [Abstract][Full Text] [Related]
31. HLA-B27 predicts a more extended disease with increasing age at onset in boys with juvenile idiopathic arthritis.
Berntson L; Damgård M; Andersson-Gäre B; Herlin T; Nielsen S; Nordal E; Rygg M; Zak M; Fasth A;
J Rheumatol; 2008 Oct; 35(10):2055-61. PubMed ID: 18785306
[TBL] [Abstract][Full Text] [Related]
32. Clinical and genetic factors associated with sacroiliitis in Crohn's disease.
Peeters H; Vander Cruyssen B; Mielants H; de Vlam K; Vermeire S; Louis E; Rutgeerts P; Belaiche J; De Vos M
J Gastroenterol Hepatol; 2008 Jan; 23(1):132-7. PubMed ID: 17725592
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology, genes and inflammatory bowel diseases in childhood.
de Mesquita MB; Civitelli F; Levine A
Dig Liver Dis; 2008 Jan; 40(1):3-11. PubMed ID: 17997369
[TBL] [Abstract][Full Text] [Related]
34. NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.
Molnar T; Hofner P; Nagy F; Lakatos PL; Fischer S; Lakatos L; Kovacs A; Altorjay I; Papp M; Palatka K; Demeter P; Tulassay Z; Nyari T; Miheller P; Papp J; Mandi Y; Lonovics J;
Dig Liver Dis; 2007 Dec; 39(12):1064-70. PubMed ID: 17964870
[TBL] [Abstract][Full Text] [Related]
35. [Transgenic rats for HLA-B27 and human beta 2 microglobulin: a model of spondyloarthritis].
Breban MA; Hammer RE; Taurog JD
Rev Rhum Ed Fr; 1993 Mar; 60(3):181-6. PubMed ID: 8293002
[No Abstract] [Full Text] [Related]
36. Inhibitory effects of the new anti-inflammatory agent, IS-741, on spontaneous colitis in HLA-B27/beta2-microglobulin transgenic rats.
Makino J; Andoh A; Hata K; Yotsuya S; Shikama H; Imamura M; Fujiyama Y; Bamba T
J Gastroenterol Hepatol; 2002 Aug; 17(8):854-60. PubMed ID: 12164961
[TBL] [Abstract][Full Text] [Related]
37. Innate immunity in Crohn's disease: the reverse side of the medal.
Dessein R; Chamaillard M; Danese S
J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S144-7. PubMed ID: 18806708
[TBL] [Abstract][Full Text] [Related]
38. Accelerated alveolar bone loss in HLA-b27 transgenic rats: an adult onset condition.
Tatakis DN; Guglielmoni P; Fletcher HM
J Rheumatol; 2002 Jun; 29(6):1244-51. PubMed ID: 12064843
[TBL] [Abstract][Full Text] [Related]
39. Increased tissue protein synthesis during spontaneous inflammatory bowel disease in HLA-B27 rats.
El Yousfi M; Breuillé D; Papet I; Blum S; André M; Mosoni L; Denis P; Buffière C; Obled C
Clin Sci (Lond); 2003 Oct; 105(4):437-46. PubMed ID: 12793856
[TBL] [Abstract][Full Text] [Related]
40. Spondyloarthropathies: progress and challenges.
Jacques P; Mielants H; De Vos M; Elewaut D
Best Pract Res Clin Rheumatol; 2008 Apr; 22(2):325-37. PubMed ID: 18455688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
